First Quadrant LP Cut By $2.41 Million Its Lydall (LDL) Holding, Iridex (IRIX) Sentiment Is 2.15

May 18, 2017 - By Adrian Erickson

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The company has market cap of $102.00 million. The Firm operates through ophthalmology segment. It currently has negative earnings. The Company’s ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation, including laser probes, and are used in the treatment of serious eye diseases, including the over three causes of irreversible blindness, such as diabetic retinopathy, glaucoma and age-related macular degeneration .

First Quadrant LP decreased Lydall Inc (LDL) stake by 97.45% reported in 2016Q4 SEC filing. First Quadrant LP sold 39,526 shares as Lydall Inc (LDL)’s stock 0.00%. The First Quadrant LP holds 1,035 shares with $64,000 value, down from 40,561 last quarter. Lydall Inc now has $824.34 million valuation. The stock rose 0.20% or $0.1 reaching $50.05. About 12,964 shares traded. Lydall, Inc. (NYSE:LDL) has risen 6.00% since April 18, 2017 and is uptrending. It has by 0.00% the S&P500.

Investors sentiment decreased to 1.2 in Q4 2016. Its down 0.33, from 1.53 in 2016Q3. It turned negative, as 14 investors sold LDL shares while 57 reduced holdings. 32 funds opened positions while 53 raised stakes. 15.14 million shares or 0.20% more from 15.11 million shares in 2016Q3 were reported. Voya Investment Ltd holds 0% in Lydall, Inc. (NYSE:LDL) or 18,991 shares. Rosenblum Silverman Sutton S F Ca reported 0.15% stake. State Of Alaska Department Of Revenue, a Alaska-based fund reported 1,860 shares. Great West Life Assurance Can owns 22,687 shares or 0% of their US portfolio. Blackrock Inv Mgmt Limited Liability accumulated 87,342 shares. Van Den Berg Mngmt I Incorporated holds 20,600 shares. The Minnesota-based Ameriprise Fin Incorporated has invested 0.01% in Lydall, Inc. (NYSE:LDL). Renaissance Limited Liability accumulated 367,400 shares. Zurcher Kantonalbank (Zurich Cantonalbank) invested in 0% or 553 shares. Aqr Mgmt Limited Liability reported 0.01% stake. Adams Diversified Equity Fund owns 19,600 shares for 0.08% of their portfolio. Royal Bancorporation Of Canada holds 819,108 shares or 0.03% of its portfolio. Ny State Teachers Retirement Systems holds 66,671 shares or 0.01% of its portfolio. 11 were reported by Parkside Bank &. Salzhauer Michael reported 5,000 shares stake.

First Quadrant LP increased Prudential Financial Inc (NYSE:PRU) stake by 19,314 shares to 23,614 valued at $2.46 million in 2016Q4. It also upped Cooper Cos Inc The (NYSE:COO) stake by 125,085 shares and now owns 129,985 shares. Applied Materials Inc (NASDAQ:AMAT) was raised too.

Since December 14, 2016, it had 1 insider purchase, and 10 insider sales for $2.74 million activity. $249,400 worth of Lydall, Inc. (NYSE:LDL) shares were sold by McDaniel Chad A.. On Monday, February 27 FARRELL MATTHEW bought $103,800 worth of Lydall, Inc. (NYSE:LDL) or 2,000 shares. The insider HUME WILLIAM J. sold $101,412. Shares for $350,886 were sold by Abbruzzi Joseph A. on Tuesday, December 20. LAUGHLAN JAMES V sold 4,700 shares worth $247,660. BURDETT KATHLEEN sold $39,428 worth of stock or 744 shares. GURLEY WILLIAM D sold $39,312 worth of stock.

Among 3 analysts covering Lydall (NYSE:LDL), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Lydall had 3 analyst reports since August 29, 2016 according to SRatingsIntel. The rating was initiated by Roth Capital with “Buy” on Wednesday, November 9. The rating was downgraded by Sidoti on Monday, August 29 to “Neutral”. As per Wednesday, November 9, the company rating was initiated by TH Capital.

Analysts await Lydall, Inc. (NYSE:LDL) to report earnings on August, 1. They expect $0.73 earnings per share, up 4.29% or $0.03 from last year’s $0.7 per share. LDL’s profit will be $12.02 million for 17.14 P/E if the $0.73 EPS becomes a reality. After $0.74 actual earnings per share reported by Lydall, Inc. for the previous quarter, Wall Street now forecasts -1.35% negative EPS growth.

Analysts await IRIDEX Corporation (NASDAQ:IRIX) to report earnings on August, 3. They expect $-0.19 EPS, down 533.33% or $0.16 from last year’s $-0.03 per share. After $-0.16 actual EPS reported by IRIDEX Corporation for the previous quarter, Wall Street now forecasts 18.75% negative EPS growth.

About 13,392 shares traded. IRIDEX Corporation (NASDAQ:IRIX) has risen 6.00% since April 18, 2017 and is uptrending. It has by 0.00% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 1 insider sale for $36,988 activity.

Ratings analysis reveals 100% of IRIDEX’s analysts are positive. Out of 3 Wall Street analysts rating IRIDEX, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. IRIX was included in 3 notes of analysts from January 26, 2016. Singular Research initiated IRIDEX Corporation (NASDAQ:IRIX) on Tuesday, January 26 with “Buy” rating. The stock of IRIDEX Corporation (NASDAQ:IRIX) has “Buy” rating given on Wednesday, December 21 by TH Capital. Roth Capital initiated the shares of IRIX in report on Wednesday, December 21 with “Buy” rating.